Overview

Targeted AntiBiotics for Chronic Obstructive Pulmonary Disease

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized multi-center trial investigating the impact of lower airway infection with P. aeruginosa in COPD patients. The aim of the study is to evaluate if targeted antibiotic therapy against P. aeruginosa can improve the prognosis in patients with COPD.
Phase:
Phase 4
Details
Lead Sponsor:
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Collaborator:
Center for Genomic Medicine, Rigshospitalet, Denmark
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Ciprofloxacin
Penicillanic Acid
Piperacillin
Piperacillin, Tazobactam Drug Combination
Tazobactam